search
Back to results

Study of Clinical and Molecular Manifestations of Genetic Disorders

Primary Purpose

Hereditary Diseases

Status
Completed
Phase
Locations
United States
Study Type
Observational
Intervention
Sponsored by
National Human Genome Research Institute (NHGRI)
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an observational trial for Hereditary Diseases focused on measuring Clinical Genetics, Etiology, Medical Screening, Prognosis, Genetic Disorders

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Patients and their families with known or suspected genetic disorders within the following categories will be recruited: Hereditary connective tissue disorders; Phacomatoses; Chromosomal disorders; Dysmorphic syndromes; Neuromuscular or neurological disorders; Inherited immunological and hematologic disorders.

Sites / Locations

  • National Human Genome Research Institute (NHGRI)

Outcomes

Primary Outcome Measures

Secondary Outcome Measures

Full Information

First Posted
November 3, 1999
Last Updated
March 3, 2008
Sponsor
National Human Genome Research Institute (NHGRI)
search

1. Study Identification

Unique Protocol Identification Number
NCT00001466
Brief Title
Study of Clinical and Molecular Manifestations of Genetic Disorders
Official Title
Clinical and Molecular Manifestations of Six Categories of Genetic Disorders
Study Type
Observational

2. Study Status

Record Verification Date
September 1999
Overall Recruitment Status
Completed
Study Start Date
October 1994 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
October 2000 (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
National Human Genome Research Institute (NHGRI)

4. Oversight

5. Study Description

Brief Summary
This study will investigate the cause and natural history (medical problems that appear over time) of certain genetic disorders. It will also try to locate the abnormal genes responsible for these conditions and eventually develop tests to predict who is likely to be affected and to what degree. Patients with known or suspected genetic disorders in certain categories, such as those involving chromosomal or metabolic abnormalities, immune system or blood disorders, abnormal growth, benign tumors, and others may be eligible for this study. Participants will be interviewed by specialists in genetics about their condition and family history. They may also be asked to have a physical examination and certain tests needed for study of the specific individual's condition. These may include collection of blood samples (up to 3 tablespoons); imaging studies, such as computerized tomography (CT), magnetic resonance imaging (MRI), ultrasound and echocardiography; skin biopsy (removal of a small sample of skin tissue under local anesthetic), and other procedures. DNA testing may reveal the genetic abnormality responsible for the disorder. Participants who so wish will have an opportunity to talk with experts about the health implications of the test results. This study may provide information that will lead to improved treatment or management of these inherited disorders, as well as more effective genetic counseling for families.
Detailed Description
Individuals and their families affected by disorders with a potentially genetic basis within six broad categories will be evaluated over time to characterize the natural and clinical history of various specific disorders. Medical and laboratory evaluations will be completed to identify areas of management concern that have not been previously described. Further protocols will be developed addressing specific disorders once a number of affected individuals have been investigated and is sufficient to query various aspects of those disorders. Issues for both diagnosis and medical management of those affected with certain genetic disorders will be collated and addressed within a national consensus conference format. In addition, phenotype to genotype correlation will be established to further understanding of specific molecular alterations on phenotypic expression. This broad-based protocol will also facilitate the training of fellows in medical genetics, graduate and post graduate training in genetics and genetic counseling.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hereditary Diseases
Keywords
Clinical Genetics, Etiology, Medical Screening, Prognosis, Genetic Disorders

7. Study Design

Enrollment
1200 (false)

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Patients and their families with known or suspected genetic disorders within the following categories will be recruited: Hereditary connective tissue disorders; Phacomatoses; Chromosomal disorders; Dysmorphic syndromes; Neuromuscular or neurological disorders; Inherited immunological and hematologic disorders.
Facility Information:
Facility Name
National Human Genome Research Institute (NHGRI)
City
Bethesda
State/Province
Maryland
ZIP/Postal Code
20892
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Study of Clinical and Molecular Manifestations of Genetic Disorders

We'll reach out to this number within 24 hrs